Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Changes to registration requirements for the offsite clinics of 340B-eligible hospitals represent the latest clash between providers, regulators and drugmakers amid the program’s exponential growth.

Sen. Peter Welch (D-Vt.) has introduced a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared with ...

The 340B program was established by Congress in 1992 to provide steep discounts to hospitals that serve a large proportion of ...

In July, the Health Resources and Services Administration announced the availability of a voluntary 340B Rebate Model Pilot Program. The program is voluntary for drugmakers, but not for hospitals, ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

The 340B Drug Pricing Program was developed more than three decades ago to help improve access to medicines for vulnerable patients 4 via manufacturer discounts to specific nonprofit hospitals and ...

In August, J&J informed disproportionate share hospitals, which care for a large number of vulnerable patients, that it would stop giving them upfront discounts on plaque psoriasis treatment Stelara ...